Wen L - Search Results

1

Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastases.

McKay R, Haider B, Duh MS, Valderrama A, Nakabayashi M, Fiorillo M, Ristovska L, Wen L, Kantoff P. McKay R, et al. Among authors: wen l. Prostate Cancer Prostatic Dis. 2017 Sep;20(3):276-282. doi: 10.1038/pcan.2017.4. Epub 2017 Feb 21. Prostate Cancer Prostatic Dis. 2017. PMID: 28220804

2

Evaluation of Treatment Patterns and Costs in Patients with Prostate Cancer and Bone Metastases.

Wen L, Yao J, Valderrama A. Wen L, et al. J Manag Care Spec Pharm. 2019 Mar;25(3-b Suppl):S1-S11. doi: 10.18553/jmcp.2019.25.3-b.s1. J Manag Care Spec Pharm. 2019. PMID: 30827188 Free PMC article.

3

Opioid Use Among Metastatic Prostate Cancer Patients With Skeletal-related Events.

Yaldo A, Wen L, Ogbonnaya A, Valderrama A, Kish J, Eaddy M, Kreilick C, Tangirala K, Shields K. Yaldo A, et al. Among authors: wen l. Clin Ther. 2016 Aug;38(8):1880-9. doi: 10.1016/j.clinthera.2016.06.018. Epub 2016 Jul 29. Clin Ther. 2016. PMID: 27478111

4

Real-World Treatment Patterns in Patients with Castrate-Resistant Prostate Cancer and Bone Metastases.

Wen L, Valderrama A, Costantino ME, Simmons S. Wen L, et al. Am Health Drug Benefits. 2019 May;12(3):142-149. Am Health Drug Benefits. 2019. PMID: 31346366 Free PMC article.

5

Estimating the Economic Impact of Sorafenib in Treatment of Locally Recurrent or Metastatic, Progressive, Differentiated Thyroid Carcinoma (DTC) That is Refractory to Radioactive Iodine (RAI) Treatment.

Sussman M, Munsell M, Valderrama A, Seal BS, Wen L. Sussman M, et al. Among authors: wen l. Value Health. 2014 Nov;17(7):A621. doi: 10.1016/j.jval.2014.08.2200. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202184 Free article. No abstract available.

6

Budget impact analysis of darolutamide for treatment of nonmetastatic castration-resistant prostate cancer.

Appukkuttan S, Farej R, Miles L, Purser M, Wen L. Appukkuttan S, et al. Among authors: wen l. J Manag Care Spec Pharm. 2021 Feb;27(2):166-174. doi: 10.18553/jmcp.2020.20330. Epub 2020 Nov 3. J Manag Care Spec Pharm. 2021. PMID: 33141615 Free PMC article.

7

A Retrospective Claims Analysis of Advanced Prostate Cancer Costs and Resource Use.

Appukkuttan S, Tangirala K, Babajanyan S, Wen L, Simmons S, Shore N. Appukkuttan S, et al. Among authors: wen l. Pharmacoecon Open. 2020 Sep;4(3):439-447. doi: 10.1007/s41669-019-00185-8. Pharmacoecon Open. 2020. PMID: 31641995 Free PMC article.

8

Are women benefiting from the Affordable Care Act? A real-world evaluation of the impact of the Affordable Care Act on out-of-pocket costs for contraceptives.

Law A, Wen L, Lin J, Tangirala M, Schwartz JS, Zampaglione E. Law A, et al. Among authors: wen l. Contraception. 2016 May;93(5):392-7. doi: 10.1016/j.contraception.2016.01.008. Epub 2016 Jan 21. Contraception. 2016. PMID: 26806631

9

Improving quality of care in oncology through healthcare payment reform.

Wen L, Divers C, Lingohr-Smith M, Lin J, Ramsey S. Wen L, et al. Am J Manag Care. 2018 Mar 1;24(3):e93-e98. Am J Manag Care. 2018. PMID: 29553283 Free article. Review.

10

Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.

Sanders JN, Turok DK, Gawron LM, Law A, Wen L, Lynen R. Sanders JN, et al. Among authors: wen l. Am J Obstet Gynecol. 2017 Jun;216(6):590.e1-590.e8. doi: 10.1016/j.ajog.2017.02.003. Epub 2017 Feb 8. Am J Obstet Gynecol. 2017. PMID: 28188772 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,085 results

Search Page

Filters